Risk factors for Human Papillomavirus Exposure and Co-factors for Cervical Cancer in Latin America and the Caribbean
The incidence of cervical cancer in Latin America and the Caribbean (LAC) is among the highest in the world. Because there are major demographic shifts happening in LAC countries (population growth, urbanization and ageing) cervical cancer incidence and mortality will likely continue to be a signifi...
- Autores:
- Tipo de recurso:
- Fecha de publicación:
- 2008
- Institución:
- Universidad del Rosario
- Repositorio:
- Repositorio EdocUR - U. Rosario
- Idioma:
- eng
- OAI Identifier:
- oai:repository.urosario.edu.co:10336/23449
- Acceso en línea:
- https://doi.org/10.1016/j.vaccine.2008.06.008
https://repository.urosario.edu.co/handle/10336/23449
- Palabra clave:
- Antiretrovirus agent
Oral contraceptive agent
Virus dna
Wart virus vaccine
Acquired immune deficiency syndrome
Article
Cancer incidence
Cancer mortality
Cancer prevention
Cancer risk
Cancer screening
Caribbean islands
Chlamydia trachomatis
Cigarette smoking
Comorbidity
Disease association
Disease course
Herpes simplex virus 2
Human
Human immunodeficiency virus infection
Human papillomavirus type 16
Human papillomavirus type 18
Nonhuman
Oral contraception
Parity
Polymerase chain reaction
Priority journal
Risk assessment
Risk factor
Sexual behavior
Sexual transmission
South and central america
Uterine cervix cancer
Virus infection
Virus transmission
Wart virus
Caribbean
Cervical cancer
Hpv
Hpv variants
Latin america
Male sexual behaviour
Risk factors
Sexual behaviour
- Rights
- License
- Abierto (Texto Completo)
id |
EDOCUR2_8c861ca5378dd7abf98dc0bfec43a681 |
---|---|
oai_identifier_str |
oai:repository.urosario.edu.co:10336/23449 |
network_acronym_str |
EDOCUR2 |
network_name_str |
Repositorio EdocUR - U. Rosario |
repository_id_str |
|
spelling |
db5cb0fc-18cb-4d69-8ae6-be1eecc6f4d3-12fff3067-d041-4766-a012-25955c064690-1cef33379-d6e1-4bd7-88f4-744459452ed2-1b552851b-29c5-4bf0-adc7-0c46eaf2d19a-1a633856a-e7e7-4d18-b31b-bcea7534db05-16c8bcbd4-74fd-4eb2-9bea-dfa19307ee4b-12020-05-26T00:02:07Z2020-05-26T00:02:07Z2008The incidence of cervical cancer in Latin America and the Caribbean (LAC) is among the highest in the world. Because there are major demographic shifts happening in LAC countries (population growth, urbanization and ageing) cervical cancer incidence and mortality will likely continue to be a significant public health problem. Overall human papillomavirus (HPV) prevalence in the LAC general population has been found to be 2-fold higher than the average worldwide prevalence. The large HPV and cancer burden may be explained by the highly prevalent HPV variants of HPV types -16 and 18, which have an increased oncogenic potential. Given the major mode of transmission of genital HPV is sexual, certain, patterns of sexual behaviour (early age at first sexual intercourse, number of sexual partners and sexual behaviour of the partner) are associated with an increased risk of HPV genital acquisition. Although HPV infection is necessary for carcinogenesis, certain co-factors (high parity, long term use of oral contraceptives, smoking and co-infection with the human immunodeficiency virus (HIV)) help in the progression from infection to cancer. Many studies that have contributed to this evidence have been carried out in LAC and are reviewed and summarised in this article. Since HPV vaccines will likely take years to implement, and many more years to show impact on disease, cervical cancer screening programmes remain as the key intervention to control disease in LAC in the years to come. © 2008 Elsevier Ltd. All rights reserved.application/pdfhttps://doi.org/10.1016/j.vaccine.2008.06.0080264410X13588745https://repository.urosario.edu.co/handle/10336/23449engElsevier BVL36 No. SUPPL. 11L16VaccineVol. 26Vaccine, ISSN:0264410X, 13588745, Vol.26, No.SUPPL. 11 (2008); pp. L16-L36https://www.scopus.com/inward/record.uri?eid=2-s2.0-50849090008&doi=10.1016%2fj.vaccine.2008.06.008&partnerID=40&md5=7fb321cb7b2588097c5a17b98ed41cddAbierto (Texto Completo)http://purl.org/coar/access_right/c_abf2instname:Universidad del Rosarioreponame:Repositorio Institucional EdocURAntiretrovirus agentOral contraceptive agentVirus dnaWart virus vaccineAcquired immune deficiency syndromeArticleCancer incidenceCancer mortalityCancer preventionCancer riskCancer screeningCaribbean islandsChlamydia trachomatisCigarette smokingComorbidityDisease associationDisease courseHerpes simplex virus 2HumanHuman immunodeficiency virus infectionHuman papillomavirus type 16Human papillomavirus type 18NonhumanOral contraceptionParityPolymerase chain reactionPriority journalRisk assessmentRisk factorSexual behaviorSexual transmissionSouth and central americaUterine cervix cancerVirus infectionVirus transmissionWart virusCaribbeanCervical cancerHpvHpv variantsLatin americaMale sexual behaviourRisk factorsSexual behaviourRisk factors for Human Papillomavirus Exposure and Co-factors for Cervical Cancer in Latin America and the CaribbeanarticleArtículohttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_6501Almonte, MaribelAlbero, GinesaMolano, MónicaCarcamo, CésarGarcía, Patricia J.Pérez, Gonzalo10336/23449oai:repository.urosario.edu.co:10336/234492022-05-02 07:37:14.602964https://repository.urosario.edu.coRepositorio institucional EdocURedocur@urosario.edu.co |
dc.title.spa.fl_str_mv |
Risk factors for Human Papillomavirus Exposure and Co-factors for Cervical Cancer in Latin America and the Caribbean |
title |
Risk factors for Human Papillomavirus Exposure and Co-factors for Cervical Cancer in Latin America and the Caribbean |
spellingShingle |
Risk factors for Human Papillomavirus Exposure and Co-factors for Cervical Cancer in Latin America and the Caribbean Antiretrovirus agent Oral contraceptive agent Virus dna Wart virus vaccine Acquired immune deficiency syndrome Article Cancer incidence Cancer mortality Cancer prevention Cancer risk Cancer screening Caribbean islands Chlamydia trachomatis Cigarette smoking Comorbidity Disease association Disease course Herpes simplex virus 2 Human Human immunodeficiency virus infection Human papillomavirus type 16 Human papillomavirus type 18 Nonhuman Oral contraception Parity Polymerase chain reaction Priority journal Risk assessment Risk factor Sexual behavior Sexual transmission South and central america Uterine cervix cancer Virus infection Virus transmission Wart virus Caribbean Cervical cancer Hpv Hpv variants Latin america Male sexual behaviour Risk factors Sexual behaviour |
title_short |
Risk factors for Human Papillomavirus Exposure and Co-factors for Cervical Cancer in Latin America and the Caribbean |
title_full |
Risk factors for Human Papillomavirus Exposure and Co-factors for Cervical Cancer in Latin America and the Caribbean |
title_fullStr |
Risk factors for Human Papillomavirus Exposure and Co-factors for Cervical Cancer in Latin America and the Caribbean |
title_full_unstemmed |
Risk factors for Human Papillomavirus Exposure and Co-factors for Cervical Cancer in Latin America and the Caribbean |
title_sort |
Risk factors for Human Papillomavirus Exposure and Co-factors for Cervical Cancer in Latin America and the Caribbean |
dc.subject.keyword.spa.fl_str_mv |
Antiretrovirus agent Oral contraceptive agent Virus dna Wart virus vaccine Acquired immune deficiency syndrome Article Cancer incidence Cancer mortality Cancer prevention Cancer risk Cancer screening Caribbean islands Chlamydia trachomatis Cigarette smoking Comorbidity Disease association Disease course Herpes simplex virus 2 Human Human immunodeficiency virus infection Human papillomavirus type 16 Human papillomavirus type 18 Nonhuman Oral contraception Parity Polymerase chain reaction Priority journal Risk assessment Risk factor Sexual behavior Sexual transmission South and central america Uterine cervix cancer Virus infection Virus transmission Wart virus Caribbean Cervical cancer Hpv Hpv variants Latin america Male sexual behaviour Risk factors Sexual behaviour |
topic |
Antiretrovirus agent Oral contraceptive agent Virus dna Wart virus vaccine Acquired immune deficiency syndrome Article Cancer incidence Cancer mortality Cancer prevention Cancer risk Cancer screening Caribbean islands Chlamydia trachomatis Cigarette smoking Comorbidity Disease association Disease course Herpes simplex virus 2 Human Human immunodeficiency virus infection Human papillomavirus type 16 Human papillomavirus type 18 Nonhuman Oral contraception Parity Polymerase chain reaction Priority journal Risk assessment Risk factor Sexual behavior Sexual transmission South and central america Uterine cervix cancer Virus infection Virus transmission Wart virus Caribbean Cervical cancer Hpv Hpv variants Latin america Male sexual behaviour Risk factors Sexual behaviour |
description |
The incidence of cervical cancer in Latin America and the Caribbean (LAC) is among the highest in the world. Because there are major demographic shifts happening in LAC countries (population growth, urbanization and ageing) cervical cancer incidence and mortality will likely continue to be a significant public health problem. Overall human papillomavirus (HPV) prevalence in the LAC general population has been found to be 2-fold higher than the average worldwide prevalence. The large HPV and cancer burden may be explained by the highly prevalent HPV variants of HPV types -16 and 18, which have an increased oncogenic potential. Given the major mode of transmission of genital HPV is sexual, certain, patterns of sexual behaviour (early age at first sexual intercourse, number of sexual partners and sexual behaviour of the partner) are associated with an increased risk of HPV genital acquisition. Although HPV infection is necessary for carcinogenesis, certain co-factors (high parity, long term use of oral contraceptives, smoking and co-infection with the human immunodeficiency virus (HIV)) help in the progression from infection to cancer. Many studies that have contributed to this evidence have been carried out in LAC and are reviewed and summarised in this article. Since HPV vaccines will likely take years to implement, and many more years to show impact on disease, cervical cancer screening programmes remain as the key intervention to control disease in LAC in the years to come. © 2008 Elsevier Ltd. All rights reserved. |
publishDate |
2008 |
dc.date.created.spa.fl_str_mv |
2008 |
dc.date.accessioned.none.fl_str_mv |
2020-05-26T00:02:07Z |
dc.date.available.none.fl_str_mv |
2020-05-26T00:02:07Z |
dc.type.eng.fl_str_mv |
article |
dc.type.coarversion.fl_str_mv |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
dc.type.coar.fl_str_mv |
http://purl.org/coar/resource_type/c_6501 |
dc.type.spa.spa.fl_str_mv |
Artículo |
dc.identifier.doi.none.fl_str_mv |
https://doi.org/10.1016/j.vaccine.2008.06.008 |
dc.identifier.issn.none.fl_str_mv |
0264410X 13588745 |
dc.identifier.uri.none.fl_str_mv |
https://repository.urosario.edu.co/handle/10336/23449 |
url |
https://doi.org/10.1016/j.vaccine.2008.06.008 https://repository.urosario.edu.co/handle/10336/23449 |
identifier_str_mv |
0264410X 13588745 |
dc.language.iso.spa.fl_str_mv |
eng |
language |
eng |
dc.relation.citationEndPage.none.fl_str_mv |
L36 |
dc.relation.citationIssue.none.fl_str_mv |
No. SUPPL. 11 |
dc.relation.citationStartPage.none.fl_str_mv |
L16 |
dc.relation.citationTitle.none.fl_str_mv |
Vaccine |
dc.relation.citationVolume.none.fl_str_mv |
Vol. 26 |
dc.relation.ispartof.spa.fl_str_mv |
Vaccine, ISSN:0264410X, 13588745, Vol.26, No.SUPPL. 11 (2008); pp. L16-L36 |
dc.relation.uri.spa.fl_str_mv |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-50849090008&doi=10.1016%2fj.vaccine.2008.06.008&partnerID=40&md5=7fb321cb7b2588097c5a17b98ed41cdd |
dc.rights.coar.fl_str_mv |
http://purl.org/coar/access_right/c_abf2 |
dc.rights.acceso.spa.fl_str_mv |
Abierto (Texto Completo) |
rights_invalid_str_mv |
Abierto (Texto Completo) http://purl.org/coar/access_right/c_abf2 |
dc.format.mimetype.none.fl_str_mv |
application/pdf |
dc.publisher.spa.fl_str_mv |
Elsevier BV |
institution |
Universidad del Rosario |
dc.source.instname.spa.fl_str_mv |
instname:Universidad del Rosario |
dc.source.reponame.spa.fl_str_mv |
reponame:Repositorio Institucional EdocUR |
repository.name.fl_str_mv |
Repositorio institucional EdocUR |
repository.mail.fl_str_mv |
edocur@urosario.edu.co |
_version_ |
1818106479508455424 |